Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery

M J Szabolcs1, P J Cannon, U Thienel

  • 1Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Insights

Activated T cells expressing CD154 interact with CD40 on various cells, contributing to coronary atherosclerosis (CA) and transplant-associated coronary artery disease (TCAD) by promoting inflammation.

Area of Science:

  • Immunology
  • Cardiovascular Pathology
  • Cell Biology

Background:

  • T cells play a role in coronary atherosclerosis (CA) and transplant-associated coronary artery disease (TCAD).
  • The precise mechanisms of T cell interactions within these vascular lesions remain unclear.
  • CD154, a T cell molecule, interacts with CD40 on target cells, inducing pro-inflammatory responses.

Purpose of the Study:

  • To investigate the potential involvement of CD154-CD40 interactions in the pathogenesis of CA and TCAD.
  • To examine the expression patterns of CD154 and CD40 in human coronary artery lesions.

Main Methods:

  • Immunohistochemical analysis of CD154 and CD40 expression on coronary artery sections from patients with CA and TCAD.
  • Utilized four distinct anti-CD154 monoclonal antibodies (mAbs).
  • Performed dual immunolabeling to assess co-expression of CD40 with CD54 (ICAM-1) and CD106 (VCAM-1).

Main Results:

  • CD154 expression was localized to infiltrating lymphocytes in both CA and TCAD lesions.
  • CD40 was significantly upregulated on intimal endothelial cells, foam cells, macrophages, and smooth muscle cells in both disease types.
  • CD40, CD54, and CD106 expression levels correlated significantly with disease severity and the number of intimal lymphocytes.

Conclusions:

  • Activated CD154-expressing T cells and CD40-expressing cells are present in CA and TCAD lesions.
  • CD154-mediated interactions with CD40+ cells may contribute to the development of CA and TCAD.
  • These findings highlight a potential therapeutic target for managing vascular inflammation in these conditions.